Trademark Overview
On Friday, July 28, 2023, a trademark application was filed for MODITOPE with the United States Patent and Trademark Office. The USPTO has given the MODITOPE trademark a serial number of 98107336. The federal status of this trademark filing is PRIORITY ACTION MAILED as of Wednesday, April 17, 2024. This trademark is owned by Scancell Limited. The MODITOPE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, for the treatment of cancer; therapeutic preparations and substances, namely, for the treatment of cancer; chemical preparations, namely, for the treatment of cancer; diagnostic reagents for medical use; DNA, antibodies and proteins that stimulate high-avidity T-cells responses for therapeutic and medical use, namely, for the treatment of cancer; pharmaceutical compounds for treatment of cancer; vaccine preparations and substances; peptide vaccines; DNA vaccines and substances